Hostname: page-component-848d4c4894-8bljj Total loading time: 0 Render date: 2024-07-05T20:51:25.564Z Has data issue: false hasContentIssue false
  • English
  • Français

The Incidence of First Hickman Catheter-Related Infection and Predictors of Catheter Removal in Cancer Patients

Published online by Cambridge University Press:  02 January 2015

Coleman Rotstein ,
Lucy Brock  and
Robin S. Roberts
Coleman Rotstein*
Affiliation:
Division of Infectious Diseases, McMaster University, Hamilton, Ontario, Canada
Lucy Brock
Affiliation:
Division of Infectious Diseases, McMaster University, Hamilton, Ontario, Canada
Robin S. Roberts
Affiliation:
Department of Medicine, McMaster University, and Hospital Research, Hamilton Civic Centre, Hamilton, Ontario, Canada
*
McMaster Medical Unit, Henderson General Hospital, 711 Concession St, Hamilton, Ontario L8V 1C3, Canada
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To describe the incidence and types of first Hickman catheter-related infection (HCRI) in cancer patients and to identify indicators for catheter removal.

Design:

Retrospective cohort study.

Setting:

A regional, tertiary, referral cancer center and its supportive care university teaching hospital.

Patients and Methods:

A retrospective review was conducted of 316 consecutive adult oncology patients who underwent Hickman catheter placement from 1986 to 1990 at a regional oncology center. HCRI was determined on the basis of clinical information incriminating the Hickman catheter as the source of infection. Patient characteristics and data about HCRIs (exit site cellulitis, tunnel infection with concomitant exit site cellulitis, bloodstream infection, and exit site cellulitis with bloodstream infection) were abstracted from patient medical records. Subsequently, univariate and multivariate analyses for the risk of HCRI and catheter removal were completed.

Results:

The incidence of first HCRI was 5.98 infections per 1,000 catheter days. Overall, 156 (49%) of 316 patients developed their first HCRI prior to catheter removal. The median time to HCRI was 90 days. Male gender (P= .0004) and hematologic malignancy (P= .0001) emerged as significant risk factors for HCRI in the univariate analysis. A Cox model verified that male gender (P=.02) and hematologic malignancy (P= .004) were associated with an enhanced risk of HCRI. There were 35 exit site infections (23%), three infections of the tunnel and the exit site (2%)) 80 bloodstream infections (51%), and another 38 bloodstream infections with concomitant exit site infections (24%). The incidence of bloodstream infection was 3.05 per 1,000 catheter days. Gram-positive pathogens outnumbered gram-negatives and fungi, with Staphylococcus epidermidis being most common. Fifty (32%) of 156 HCRIs resulted in catheter removal. Predictors of Hickman catheter removal in the univariate analysis were bloodstream infection (P= .046) and pathogen type (P= .006). Multiple regression analysis suggested that having a gram-negative (P= .014) or fungal (P= .057) pathogen was the most important factor for catheter removal.

Conclusions:

These data suggest that first HCRIs occur more commonly in male patients with hematologic malignancies than in patients with solid tumors. The removal of Hickman catheters in oncology patients probably is predicated on the causative pathogen, but further investigations are necessary to delineate this issue.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 16 , Issue 8 , August 1995 , pp. 451 - 458
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Dilworth, JA, Mandell, GL. Infections in patients with cancer. Semin Oncol 1975:2:349–359.Google ScholarPubMed
2. Landoy, Z, Rotstein, C, Lucey, J, Fitzpatrick, J. Hickman-Broviac catheter use in cancer patients. J Surg Oncol 1984;26:215218.Google Scholar
3. Lowder, JN, Lazarus, HM. Herzig, RH. Bacteremias and fungemias in oncologic patients with central venous catheters: changing spectrum of infection. Arch Intern Med 1982;142:1456–1459.CrossRefGoogle ScholarPubMed
4. Martino, P, Micozzi, A, Venditi, M, et al. Catheter-related right-sided endocarditis in bone marrow transplant recipients. Rev Infect Dis 1990;12:250–257.CrossRefGoogle ScholarPubMed
5. Reed, WP Newman, KA. De Jongh, C, et al. Prolonged venous access for chemotherapy by means of the Hickman catheter. Cancer 1983;52:185–192.Google Scholar
6. Press, OW, Ramsey, PG, Larson, EB, Fefer, A, Hickman, RO. Hickman catheters in patients with malignancies. Medicine 1984;63:189–200.Google Scholar
7. Raad, I, Davis, S. Becker, M, et al. Low infection rate and long durability of nontunneled silastic catheters: a safe and cost-effective alternative for long-term venous access. Arch Intern Med 1993;153:1791–1796.CrossRefGoogle ScholarPubMed
8. Hickman, RO. Buckner, CD, Clift, RA. et al. A modified right atria1 catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979;148:871–875.Google Scholar
9. Larson, EB, Wooding, M, Hickman, RO. Infectious complications of right atrial catheters used for venous access in patients receiving intensive chemotherapy. Surg Gynecol Obstet 1981;153:369–373.Google ScholarPubMed
10. Reilly, JJ Jr. Steed, DL, Ritter, PS. Indwelling venous access catheters in patients with acute leukemia. Cancer 1984;53:219–223.3.0.CO;2-2>CrossRefGoogle ScholarPubMed
11. Benezra, D. Kiehn, TE, Gold, JWM, Brown, AE, Turnbull, ADM, Armstrong, D. Prospective study of infections in indwelling central venous catheters using quantitative blood cultures. Am J Med 1988;85:495–498.Google Scholar
12. Hiemenz, J. Skelton, J, Pizzo, PA. Perspective on the management of catheter-related infections in cancer patients. Pediatr Infect Dis J 1986;5:6–11.CrossRefGoogle ScholarPubMed
13. Dugdale, DC, Ramsey, PG. Staphylococcus aureus bacteremia in patients with Hickman catheters. Am J Med 1990;89:137–141.CrossRefGoogle ScholarPubMed
14. Cotton, DJ, Gill, VJ, Marshall, DJ, Gress, J, Thaler, M, Pizzo, PA. Clinical features and therapeutic interventions in 17 cases of Bacillus bacteremia in an immunosuppressed patient population. J Clin Microbial 1987;25:672–674.CrossRefGoogle Scholar
15. Banerjee, C, Bustamante, CI, Wharton, R, Talley, E, Wade, JC. Bacillus infections in patients with cancer. Arch Intern Med 1988;148:1769–1774.Google Scholar
16. Lecciones, JA, Lee, JW, Navarro, EE, et al. Vascular catheter-associated fungemia in patients with cancer: an analysis of 155 episodes. Clin Infect Dis 1992;14:875–883.CrossRefGoogle ScholarPubMed
17. Hughes, WT, Armstrong, D, Bodey, GF: et al. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 1990;161:381–396.CrossRefGoogle ScholarPubMed
18. Mayhall, CG, Remington, JS, Swartz, MN, eds. Diagnosis and Management of Infections of Implantable Devices Used for Prolonged Venous Access in Current Clinical Topics in Infectious Diseases. Boston, MA: Blackwell Scientific Publications; 1992:83–110.Google Scholar
19. Groeger, JS, Lucas, AB, Thaler, HT, et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1993;119:1168–1174.CrossRefGoogle ScholarPubMed
20. Pizzo, PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993;328:1323–1332.Google ScholarPubMed
21. Harvey, MP, Trent, RJ, Joshua, DE, Ramsey-Stewart, G, Storey, DW. Kronenberg, H. Complications associated with indwelling venous Hickman catheters in patients with hematological disorders. Aust N Z J Med 1986;16:211–215.CrossRefGoogle ScholarPubMed
22. Raaf, JR. Results from use of 826 vascular access devices in cancer patients. Cancer 1985;55:1312–1321.Google Scholar
23. Raad, II, Bodey, GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis 1992;15:197–210.Google Scholar
24. Paya, CV, Guerra, L, March, HM, Farnell, MB, Washington, JH, Thompson, RL. Limited usefulness of quantitative culture of blood drawn through the device for diagnosis of intravascular-device-related bacteremia. J Clin Microbial 1989;27:1431–1433.Google Scholar
25. Wade, JC, Schimpff, SC, Newman, KA, Wiernik, PH. Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Ann Intern Med 1982;97:503–508.CrossRefGoogle ScholarPubMed
26. Hoffman, KK, Weber, DJ, Samsa, GP, Rutala, WA. Transparent polyurethane film as an intravenous catheter dressing: a meta-analysis of the infection risks. JAMA 1992;267:2072–2076.Google Scholar
27. Lim, SH, Smith, MP, Salooja, N, Machin, SI, Goldstone, AH. A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for hematological malignancies. J Antimicrob Chemother 1991;28:109–116.CrossRefGoogle Scholar
28. Rozenberg-Arska, M. Dekker, AW, Verhoef, J. Prevention of infections in granulocytopenic patients by fluorinated quinolones. Rev Infect Dis 1989;11(suppl 5):1231S–1236S.CrossRefGoogle ScholarPubMed
29. Winston, DJ, Chandrasekar, PH. Lazarus, HM, et al. Fluconazole prophylaxis of fungal infections in patients with acute leukemia: results of a randomized placebo-controlled, double-blind, multicenter trial. Ann Intern Med 1993;118:495–503.Google Scholar
30. Schwartz, C, Hendrickson, KJ, Roghmann, K, Powell, K. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol 1990;8:1591–1597.CrossRefGoogle ScholarPubMed
31. Attal, M, Schlaifer, D, Rubie, H, et al. Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective randomized trial. J Clin Oncol 1991;9:865870.Google Scholar
32. Groeger, JS, Lucas, AB, Coit, D, et al. A prospective, randomized evaluation of the effect of silver impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients. Ann Surg 1993;218:206–210.Google Scholar
33. Allo, MD, Miller, J, Townsend, T, Tan, C. Primary cutaneous aspergillosis associated with Hickman intravenous catheters. N Engl J Med 1987;317:1105–1108.CrossRefGoogle ScholarPubMed